Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zivo Bioscience, Inc.ZIVO · Entity 9611 | Chief Financial Officer | April 06, 2020 | December 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zivo Bioscience, Inc.
Report date April 06, 2020 · Filed December 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,151 |
Ending reported balance
After 2020-09-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-09-09 · Exercise / conversion · Acquired 250,000 · Balance 250,000 Row 2 · 2020-09-09 · Tax withholding · Disposed 235,849 · Balance 14,151 |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2020-04-06 | Direct | 0 |
Reported balance
After 2020-04-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-06 · Tax withholding · Disposed 29,833 · Balance 0 |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.09 · Expires 2020-05-13 | Direct | 0 |
Reported balance
After 2020-04-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-04-21 · Tax withholding · Disposed 50,000 · Balance 0 |
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2020-09-10 | Direct | 0 |
Reported balance
After 2020-09-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-09-09 · Tax withholding · Disposed 250,000 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2020 Filed Dec 2, 2020 00:29 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Tax withholdingCommon Stock Purchase Warrant · Derivative | 250,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001078782-20-000934 · primary_doc.xml · derivative · entry 5 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2020-09-10 Read SEC document |
| September 09, 2020 Filed Dec 2, 2020 00:29 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Tax withholdingCommon Stock | 235,849 | $0.11 | $25,943.39 |
DisclosureSEC source: 0001078782-20-000934 · primary_doc.xml · nonDerivative · entry 2 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,151 Read SEC document |
| September 09, 2020 Filed Dec 2, 2020 00:29 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Exercise / conversionCommon Stock | 250,000 | $0.10 | $25,000.00 |
DisclosureSEC source: 0001078782-20-000934 · primary_doc.xml · nonDerivative · entry 1 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2020 Filed Dec 2, 2020 00:29 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Tax withholdingCommon Stock Purchase Warrant · Derivative | 50,000 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001078782-20-000934 · primary_doc.xml · derivative · entry 4 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2020-05-13 Read SEC document |
| April 06, 2020 Filed Dec 2, 2020 00:29 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | Tax withholdingCommon Stock Purchase Warrant · Derivative | 29,833 | $0.00 Strike: $0.09 | $0.00 |
DisclosureSEC source: 0001078782-20-000934 · primary_doc.xml · derivative · entry 3 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,833 shares Expires 2020-04-06 Read SEC document |
| March 04, 2020 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Option · Derivative | 2,000,000 | Not disclosed Strike: $0.15 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 11 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2030-03-04 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| October 28, 2019 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 10 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-28 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| September 26, 2019 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 9 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2024-09-26 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 07, 2019 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 8 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-08-07 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| May 13, 2019 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 7 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-05-13 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| February 13, 2019 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 6 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-02-13 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| November 14, 2018 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.14 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 5 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-11-14 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| September 28, 2018 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.14 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 4 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2023-09-28 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 14, 2018 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 3 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-08-14 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| April 23, 2018 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 2 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-04-23 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| February 21, 2018 Filed Apr 8, 2020 19:24 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.11 | Not disclosed |
DisclosureSEC source: 0001078782-20-000238 · primary_doc.xml · derivative · entry 1 RICE II PHILIP M · CIK 0001534921 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2023-02-21 F1 · price: The warrants were issued to the reporting person as compensation for acting as a Chief Financial Officer. Read SEC document |
| November 08, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 6,000,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 26 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000,000 Underlying: Common Stock · 6,000,000 shares Expires 2022-11-08 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| October 19, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 25 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2022-10-19 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 11, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 500,000 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 24 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2022-09-11 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 13, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.06 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 23 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2022-08-13 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| May 12, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 22 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2022-05-12 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| March 31, 2017 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 21 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2022-03-31 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| November 14, 2016 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 20 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2021-11-14 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 10, 2016 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 250,000 | Not disclosed Strike: $0.05 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 19 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2021-09-10 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 12, 2016 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 18 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2021-08-12 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| May 13, 2016 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 17 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2021-05-13 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| March 29, 2016 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 16 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2021-03-29 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| November 13, 2015 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.08 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 15 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2020-08-13 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| September 10, 2015 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 250,000 | Not disclosed Strike: $0.10 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 14 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2020-09-10 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 13, 2015 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 13 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2020-08-13 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| May 13, 2015 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 12 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2020-05-13 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| April 06, 2015 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 11 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2020-04-06 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| November 14, 2014 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.09 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 10 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-11-14 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 14, 2014 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.14 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 9 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-08-14 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| May 14, 2014 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.19 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 8 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-05-14 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| March 31, 2014 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.17 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 7 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2019-03-31 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| January 04, 2014 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.38 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 6 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2017-01-04 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. F1 · balance_after: These warrants have expired. Read SEC document |
| November 18, 2013 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 5 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2018-11-18 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| August 10, 2013 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 4 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2018-08-10 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| April 30, 2013 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 557,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 3 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,000 Underlying: Common Stock · 557,000 shares Expires 2018-04-30 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| April 01, 2013 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.25 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 2 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2018-04-01 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. Read SEC document |
| January 04, 2013 Filed Feb 9, 2018 22:12 UTC | Zivo Bioscience, Inc. ZIVO · Entity 9611 | GrantCommon Stock Purchase Warrant · Derivative | 50,000 | Not disclosed Strike: $0.12 | Not disclosed |
DisclosureSEC source: 0001078782-18-000113 · primary_doc.xml · derivative · entry 1 RICE II PHILIP M · CIK 0001534921 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2016-01-04 F2 · price: The warrants were issued to the reporting person as compensation for acting as a director. F1 · balance_after: These warrants have expired. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.